Leptomeningeal metastasis (LM) is a complication of deeper concerns due to its increasing incidence rate, limited treatment options, and dismal survival outcomes in patients with EGFR-mutated non-small cell lung cancer (NSCLC) [1]. Here, EGFR is linked to lymphangioma.